News
Studies have shown that fewer post-LASIK eyes end up within that coveted plus or minus 0.50 D of the intended target compared ...
In episode 1, Bill Trattler, MD, shares practical advice on documentation, patient communication, keratoconus management, and ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Surgeons are seeing many Generation X patients seeking refractive lens exchange or cataract surgery. Patients in this ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Kriya is developing gene therapies targeting chronic diseases such as geographic atrophy, trigeminal neuralgia, and type 1 diabetes.
ASRS 2025: Neighborhood-level characteristics associated with delay in surgery and loss to follow-up
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Advanz Pharma and Alvotech announced AVT06, a biosimilar to Eylea, was approved for neovascular age-related macular ...
Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...
Best disease, or vitelliform macular dystrophy, is a rare, inherited retinal condition causing macular degeneration by ...
Tear trough filler, using HA, offers a nonsurgical option for under-eye rejuvenation, requiring precise anatomical knowledge ...
Dan Ignaszewski explains how the national advocacy campaign aims to unite patients, researchers, and clinicians to protect ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results